FDA Approves Gleevec for Children With Acute Lymphoblastic Leukemia

Published January 28, 2013

FDA approves Gleevec for children with acute lymphoblastic leukemia

Filed under: drug treatment programs maryland

… treat children with Ph+ ALL. “We are pleased that the number of cancer medications for children are on the rise,” said Richard Pazdur, M.D., director of the Office of Hematology and Oncology Products in the FDA's Center for Drug Evaluation and …
Read more on PharmaLive (press release) (subscription)

IRHOM2-targeted drugs can effectively treat patients with rheumatoid arthritis

Filed under: drug treatment programs maryland

To work, it must be cut loose by signaling scissors called TACE (TNF-alpha converting enzyme)," said Carl Blobel, M.D., Ph.D., program director of the Arthritis and Tissue Degeneration Program at HSS. While blocking TACE could be another way to treat …
Read more on News-Medical.net

Depression Is Still a Mystery – We Need a New Model

Filed under: drug treatment programs maryland

If the chain of explanation running from genes to the synapses and finally to the pharmaceutical lab is broken, a host of doubts arises. Is depression a brain disease in the first place, or is it, as psychiatry assumed before the arrival of modern drug …
Read more on San Francisco Chronicle